| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
State Key Laboratory of Biomembrane and Membrane Biotechnology, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing, China
Correspondence: Address reprint requests to Dr. Yong-Bin Yan, Dept. of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, PR China. Tel.: 86-10-6278-3477; Fax: 86-10-6277-1597; E-mail: ybyan{at}tsinghua.edu.cn.
| ABSTRACT |
|---|
|
|
|---|
65°C. In this research, the sequential events in ACYI thermal denaturation were investigated by a combination of spectroscopic methods and related resolution-enhancing techniques. Interestingly, the results from fluorescence and infrared (IR) spectroscopy clearly indicated that a pretransitional stage existed at temperatures from 50°C to 66°C. The thermal unfolding of ACYI might be a three-state process involving an aggregation-prone intermediate appearing at
68°C. The pretransitional structural changes involved the partial unfolding of the solvent-exposed ß-sheet structures and the transformation of about half of the Class I Trp fluorophores to Class II. Our results also suggested that the usage of resolution-enhancing techniques could provide valuable information of the step-wise unfolding of proteins. | INTRODUCTION |
|---|
|
|
|---|
Unlike the thoroughly studied biochemical properties of ACYI, no high-resolution crystal structure of ACYI is presently available. Recently, the crystal structure of a D-aminoacylase from Alcaligenes faecalis was determined (16
). However, the low homology among the amino acid sequences of D- and L-aminoacylases available suggests that they may have different fold and catalytic mechanisms (2
). Based on mass spectrometric results, a structural model of ACYI was proposed, and it was suggested that each ACYI subunit might be composed of two domains with
/ß folds: the catalytic domain and the dimerization domain (17
). The folding of ACYI has been characterized to be a three-state process involving an inactive dimeric intermediate with molten globule-like characteristics (18
,19
). This suggested that the two domains of ACYI might fold hierarchically and the folding of the catalytic domain is the rate-limiting step. Despite the large amounts of ACYI that exist in mammalian kidney and liver, the reactivation of ACYI is particularly difficult in vitro (19
21
), which suggests that the folding of ACYI in vivo might be assisted by the possible intracellular molecular chaperones and/or osmolytes. Previous studies have indicated that the zinc ion is essential for the stabilization of the active site conformation as well as the protein structure (18
,22
24
).
As a zinc-dependent enzyme, ACYI is quite stable against denaturation induced by heat stress. It can retain its activity when subjected to heat treatment at 60°C for 60 min (25
), whereas it is irreversibly unfolded when heated at temperatures above 65°C. The optimal temperature for ACYI activity is
60°C (25
,26
), which indicates that it can be regarded as a thermostable enzyme. In general, the thermal denaturation of proteins can be demonstrated by a two-state thermodynamic mechanism. However, considerable structural changes were observed for ACYI when heated to 60°C (26
). In this research, the sequential events in ACYI thermal unfolding were investigated by a combination of spectroscopic methods and the related resolution-enhancing techniques. Interestingly, the results from fluorescence and infrared (IR) spectroscopy clearly indicated that pretransitional conformational changes occurred at temperatures from 50°C to 66°C during ACYI thermal denaturation. The thermal unfolding of ACYI might be a three-state process involving an intermediate appearing at
68°C. Considering the commercial importance of aminoacylase, the results herein might facilitate the optimization of the conditions for the industrial use of ACYI. Moreover, the strategies used in this research might also facilitate the characterization of the potential pretransitional changes in the thermal transitions of other thermostable or thermophilic proteins.
| MATERIALS AND METHODS |
|---|
|
|
|---|
(5
Aminoacylase activity assay
The enzyme was dissolved in 30 mM Tris-HCl, pH 7.5. The enzymatic activity was determined by measuring the absorbance at 238 nm accompanied with hydrolysis of the substrate and using the molar absorption coefficient
238 = 185 M1cm1 as reported by Kordel and Schneider (5
,6
), except that chloroacetyl-L-leucine was used instead of pure-L-enantiomorph. The final enzyme concentration for the activity assay was 2 µM (
0.18 mg/ml). The thermal dependence of ACYI activity was measured by incubating the enzyme solutions at given temperatures for 30 min, and then the activity assay was performed by mixing the enzyme solutions and reaction buffers preheated at the same temperatures.
Calorimetric measurements
Calorimetric measurements were carried out using a Setaram Micro DSC III differential scanning calorimeter (DSC) with a 0.8-ml cell (Setaram Scientific and Industrial Equipment, Caluire, France). The DSC curves were obtained using a scanning rate of 0.5 or 1.0 K/min from 20°C to 90°C. The enzymes were dissolved in 30 mM Tris-HCl, pH 7.5, with a final concentration of 1.0 or 1.5 mg/ml. Reversibility of the thermal transition was examined by reheating the samples after cooling from the first scan.
Infrared spectroscopy
The IR samples were prepared by dissolving ACYI in 100 mM deuterated phosphate saline buffer at a concentration of 50 mg/ml. The fully deuterated samples were obtained by incubating the protein solutions in a water bath at 50°C for 15 min, and then the samples were cooled to room temperature and lyophilized. The proteins were redissolved in D2O and centrifuged at 6000 x g for 10 min before use with a final pD of 8.0 adjusted using DCl or NaOD. The pD values were read directly from an Orion pH meter (Orion Research, Beverly, MA) and no corrections were made for isotope effects.
The Fourier transform infrared (FTIR) spectra were obtained using the published procedures (27
). In brief, all FTIR experiments were performed on a Perkin-Elmer Spectrum 2000 spectrometer (Wellesley, MA) equipped with a dTGS detector. About 30 µl protein samples were placed between a pair of CaF2 windows separated by a 50-µm Teflon spacer. Spectra were collected from 30°C to 98°C at intervals of 2°C with a spectral resolution of 4 cm1 and 256 scans. Baseline correction was performed before the further analysis of the IR data. Fourier self-deconvolution (FSD) was performed using the software Spectrum v3.02 (Perkin-Elmer) with a
factor of 2.5 and Bessel smoothing of 70%, and second derivative was carried out using the algorithm in the software with a nine-point Savitzky-Golay smoothing. The transition curves of the amide I' bands were obtained according to a method described previously (28
). The amide I' bands were assigned according to previous publications (24
).
Two-dimensional infrared correlation (2D IR) analysis was carried out using SDIAPP software developed in-house (27
) according to the generalized two-dimensional (2D) correlation algorithm (29
). The synchronous and asynchronous correlation plots were constructed from nonnormalized FSD spectra. The averaged spectrum was used as a reference. Similar plots with relatively lower resolution could be obtained when using the original spectra for the 2D correlation analysis. The 2D IR plots were presented as contour maps produced by drawing the contour lines every 10% off from the maximum intensity of the whole correlation map. The sequence of the events was characterized by analyzing the signs of the peaks in the 2D IR correlation plots using rules proposed by Noda (29
). The attempts to avoid artifacts in the 2D IR plots have been described in detail elsewhere (30
).
Intrinsic fluorescence spectroscopy
The samples for the fluorescence measurements were prepared by dissolved ACYI in 30 mM Tris-HCl (pH 7.5) with a final concentration of 1 mg/ml. To evaluate the effect of the protein concentration on the fluorescence spectra, a diluted sample solution with a final concentration of 0.2 mg/ml was also prepared. Details with regard to the intrinsic fluorescence experiments were the same as those described before (30
). In brief, the intrinsic Trp fluorescence emission spectra were measured using a Hitachi F-2500 spectrofluorometer (Tokyo, Japan) using 1-cm path-length cuvettes with an excitation wavelength of 295 nm. The spectra were measured after the samples had been equilibrated for 2 min at given temperatures controlled with a circulating water bath. Parameter A, which reflects the spectral shape of the intrinsic Trp fluorescence (31
), was obtained by dividing the fluorescence intensity at 320 nm by the intensity at 365 nm.
The fitting of the fluorescence spectra was performed using the discrete states model of Trp residues in proteins and was calculated by a program developed in-house (30
) based on the SIMS algorithms of decomposition (32
). The fluorescence spectra were normalized before calculation. Since no crystal structure of ACYI is available, all four of the components (A and S, I, II, and III) of Trp fluorescence defined previously (33
,34
) were included in the curve-fitting process. The best fitting results were obtained according to the least root mean square criterion.
Phase diagram analysis of IR and fluorescence data
The phase diagram analysis, which is a sensitive tool to detect folding intermediates, was carried out as described previously (35
). The original IR or fluorescence data were normalized by the corresponding intensity of the spectra recorded at 30°C. The phase diagram was constructed by the IR intensity at 1637 cm1 vs. 1628 cm1 or the fluorescence intensity at 320 nm vs. that at 365 nm at different temperatures. Each straight line in the phase diagram reflects an "all-or-none" process, and the joint position of two lines for a transition process indicates that an intermediate appeared at the corresponding temperature.
| RESULTS AND DISCUSSION |
|---|
|
|
|---|
65°C, which is consistent with the previous observations (25
31 kJ mol1. The activity decreased rapidly at higher temperatures (>65°C) due to inactivation of the enzyme. These results suggested that the active site of the enzyme might remain intact at temperatures below 65°C under our conditions, whereas the loss of activity at temperatures above 65°C might be due to heat-induced unfolding.
|
|
-helix (1651 cm1),
-helix and/or 310 helix (1660 cm1), ß-sheet (1629, 1637, and 1682 cm1), ß-turn (1668 and 1674 cm1), and random coil (1644 cm1). This assignment is consistent with the previous results (24
/ß structure of ACYI (17
|
|
|
ACYI contains eight Trp residues in each of its two subunits (47
,48
), and the eight Trp residues are distributed in both the peptidase and dimerization domain (13
,17
). Thus the intrinsic Trp fluorescence was used to investigate the changes of the tertiary structure of ACYI during thermal denaturation. To ensure the accuracy of the curve fitting, two samples with final protein concentrations of 0.2 and 1 mg/ml were prepared and used for the Trp fluorescence analysis. The curves from the diluted solution (data not shown) were similar to those presented in Figs. 6 and 7 but with greater errors due to the relatively low signal/noise ratio and intactness of the thermal transition curve. Thus the sample with a concentration of 1 mg/ml was used for further analysis. Consistent with previous observations (26
), the intensity of the intrinsic Trp fluorescence decreased with the increase of temperature, and meanwhile, the emission maximum wavelength red shifted from
333 nm to 340 nm (Fig. 6). At temperatures above 80°C, the fluorescence was significantly affected by the appearance of serious aggregation. The change of the intensity at 330 nm could not be fitted to a simple two-state model, and a platform could be found at the temperature range of 52°C60°C (Fig. 6 B). Parameter A, which is a sensitive tool to reflect the position and shape of the Trp fluorescence spectrum, slightly decreased when the temperature increased to 64°C, and then an abrupt decrease was observed. To better understand the step-wise changes of the different Trp fluorophores, the spectrum recorded at each temperature was fitted using the discrete states model of Trp residues in proteins (30
,32
,34
). Since no high-resolution structure of ACYI is available, all of the Trp fluorophores (Classes A and S, I, II, and III) defined previously (34
) were included in the fitting procedure. The native ACYI contained Class I (
60%) and II (
40%) fluorophores, but did not contain Classes A, S, or III (Fig. 7 A). This indicated that most of the Trp residues in ACYI were buried in the interior (Class I) or exposed to bonded water (Class II), and no Trp residues were in a highly hydrophobic (Class A and S) or fully solvent-exposed (Class III) microenvironment. This result is, to some extent, consistent with the predicted ACYI structure (17
). The intensity changes of the various fluorophores upon heating could be classified into three distinct stages. From 30°C to 50°C, no significant changes were observed for the four components. The content of the Class I component began to decrease when heated to
50°C, and meanwhile the Class II component began to increase and reached a level of
60% at 66°C. The other components remained at the same level as at 30°C in the temperature range of 5066°C. At temperatures above 66°C, the content of the Class I fluorophore decreased continuously, whereas the Class III component increased. At 80°C, ACYI contains
10% Class I, 60% Class II, and 30% Class III fluorophores, which suggested that most Trp residues in the protein were accessible by solvent. It is noteworthy that the same results could be obtained for the diluted sample with a concentration (0.2 mg/ml) similar to that used for the activity assay, except that the transitions occurred at a temperature
2°C higher than the 1 mg/ml sample.
|
|
68°C.
|
65°C. Interestingly, considerable conformational changes were observed before the enzyme was fully inactivated by high temperature. The IR and fluorescence results strongly suggested that the thermal unfolding of ACYI could be illustrated as a two-stage process involving an intermediate: native state (N)
intermediate state (I)
aggregates (A). The I
A transition, which was referred to as the dominant unfolding process above, began at around 70°C and the midpoint of the transition (T1/2) occurred at
84°C (see Table 1). A significant intensity decrease was observed for most IR bands from native secondary structures, accompanied with the exposure of most Trp residues to water and the formation of aggregates during the I
A transition. The N
I transition, which was referred to as the pretransitional change, ended at
68°C and the T1/2 occurred at
60°C (see Table 1). The structural changes in this stage involved the partial unfolding of the solvent-exposed ß-sheet structures and the transformation of about half of the Class I Trp fluorophores to Class II (see Fig. 7). The decrease in the content of Class I Trp fluorophores suggested that the intermediate had a loose tertiary structure, which allowed the penetration of water molecules into the hydrophobic interior. This two-stage scheme is similar to that from the chemical unfolding/refolding studies of ACYI (18
-helix and ß-sheet structures, and both contain several Trp residues. It has been proposed that the catalytic domain contains a ß-sheet sandwiched between
-helices and a second ß-sheet located on the surface, whereas the dimerization domain consists of a ß-sheet flanked on one side by two
-helices (17
|
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
Submitted on July 19, 2006; accepted for publication October 11, 2006.
| REFERENCES |
|---|
|
|
|---|
2. Hernick, M., and C. A. Fierke. 2005. Zinc hydrolases: the mechanisms of zinc-dependent deacetylases. Arch. Biochem. Biophys. 433:7184.[CrossRef][Medline]
3. Seibert, C. M., and F. M. Raushel. 2005. Structural and catalytic diversity within the amidohydrolase superfamily. Biochemistry. 44:63836391.[CrossRef][Medline]
4. Birnbaum, S. M. 1955. Aminoacylase, amino acid acylase I and II from hog kidney. Methods Enzymol. 2:115119.[Medline]
5. Kordel, W., and F. Schneider. 1976. Chemical investigation on pig kidney aminoacylase. Biochim. Biophys. Acta. 445:446457.[Medline]
6. Kordel, W., and F. Schneider. 1976. Chemical modification of two tryptophan residues abolishes the catalytic activity of aminoacylase. Hoppe Seylers Z. Physiol. Chem. 357:11091115.[Medline]
7. Schmiedeberg, O. 1881. Über Spaltungen und Synthesen im Thierkörper. Naunyn-Schmiedebergs Arch. Exp. Path. Pharma kol. 14:379392.[CrossRef]
8. Endo, Y. 1978. N-Acyl-L-aromatic amino acid deacylase in animal tissues. Biochim. Biophys. Acta. 523:207214.[Medline]
9. Miller, Y. E., and B. Kao. 1989. Monoclonal antibody based immunoassay for human aminoacylase-1. J. Immunoassay. 10:129152.[Medline]
10. Gade, W., and J. Brown. 1981. Purification, characterization and possible function of
-N-acylpeptide hydrolase from bovine liver. Biochim. Biophys. Acta. 662:8693.[Medline]
11. Perrier, J., A. Durand, T. Giardina, and A. Puigserver. 2005. Catabolism of intracellular N-terminal acetylated proteins: involvement of acylpeptide hydrolase and acylase. Biochimie. 87:673685.[Medline]
12. Van Coster, R. N., E. A. Gerlo, T. G. Giardina, U. F. Engelke, J. E. Smet, C. M. De Praeter, V. A. Meersschaut, L. J. De Meirleir, S. H. Seneca, B. Devreese, J. G. Leroy, S. Herga, J. P. Perrier, R. A. Wevers, and W. Lissens. 2005. Aminoacylase I deficiency: a novel inborn error of metabolism. Biochem. Biophys. Res. Commun. 338:13221326.[CrossRef][Medline]
13. Sass, J. O., V. Mohr, H. Olbrich, U. Engelke, J. Horvath, M. Fliegauf, N. T. Loges, S. Schweitzer-Krantz, R. Moebus, P. Weiler, A. Kispert, A. Superti-Furga, R. A. Wevers, and H. Omran. 2006. Mutations in ACY1, the gene encoding aminoacylase 1, cause a novel inborn error of metabolism. Am. J. Hum. Genet. 78:401409.[CrossRef][Medline]
14. Chenault, H. K., J. Dahmer, and G. M. Whitesides. 1989. Kinetic resolution of unnatural and rarely occurring amino acids: enantioselective hydrolysis of N-acyl amino acids catalyzed by acylase I. J. Am. Chem. Soc. 111:63546364.[CrossRef]
15. Wang, H. J., J. H. Bai, D. S. Liu, T. Zhang, and H. M. Zhou. 1999. Preparation and properties of immobilized pig kidney aminoacylase and optical resolution of N-acyl-DL-alanine. Appl. Biochem. Biotechnol. 76:183191.[CrossRef][Medline]
16. Liaw, S.-H., S.-J. Chen, T.-P. Ko, C.-S. Hsu, C.-J. Chen, A. H.-J. Wang, and Y.-C. Tsai. 2003. Crystal structure of D-aminoacylase from Alcaligenes faecalis DA1. A novel subset of amidohydrolases and insights into the enzyme mechanism. J. Biol. Chem. 278: 49574962.
17. D'Ambrosio, C., F. Talamo, R. M. Vitale, P. Amodeo, G. Tell, L. Ferrara, and A. Scaloni. 2003. Probing the dimeric structure of porcine aminoacylase 1 by mass spectrometric and modeling procedures. Biochemistry. 42:44304443.[CrossRef][Medline]
18. Bai, J.-H., D. Xu, H.-R. Wang, S.-Y. Zheng, and H.-M. Zhou. 1999. Evidence for the existence of an unfolding intermediate state for aminoacylase during denaturation in guanidine solutions. Biochim. Biophys. Acta. 1430:3945.[CrossRef][Medline]
19. Xie, Q., and H.-M. Zhou. 2004. Refolding intermediate of guanidine hydrochloride denatured aminoacylase. Int. J. Biochem. Cell Biol. 36:13321340.[CrossRef][Medline]
20. Kim, S.-H., Y.-B. Yan, and H.-M. Zhou. 2006. Role of osmolytes as chemical chaperones during the refolding of aminoacylase. Biochem. Cell Biol. 84:3038.[CrossRef][Medline]
21. Kim, S.-H., J. Zhang, Y. Jiang, H.-M. Zhou, and Y.-B. Yan. 2006. Assisting the reactivation of guanidine hydrochloride-denatured aminoacylase by hydroxypropyl cyclodextrins. Biophys. J. 91:686693.
22. Heese, D., S. Berger, and K. H. Röhm. 1990. Nuclear magnetic relaxation studies of the role of the metal ion in Mn2+-substituted aminoacylase I. Eur. J. Biochem. 188:175180.[Medline]
23. Wang, Z.-X., H.-B. Wu, X.-C. Wang, H.-M. Zhou, and C.-L. Tsou. 1992. Kinetics of the course of inactivation of aminoacylase by 1,10-phenanthroline. Biochem. J. 281:285290.
24. Zhang, Y., P.-R. Chen, B. He, and H.-M. Zhou. 1994. Secondary structure of holo-enzyme and apoenzyme of aminoacylase using CD and FTIR spectroscopy. Sci. China B. 37:14711478.
25. He, B., M. Yan, T. Zhang, and H.-M. Zhou. 1994. Unfolding and inactivation during thermal denaturation of aminoacylase. Chin. Sci. Bull. 39:11221127.
26. Xie, Q., F. G. Meng, and H. M. Zhou. 2004. Low temperature induced conformational changes of aminoacylase. Tsinghua Sci. Technol. 9:7680.
27. Yan, Y.-B., Q. Wang, H.-W. He, X.-Y. Hu, R.-Q. Zhang, and H.-M. Zhou. 2003. Two-dimensional infrared correlation spectroscopy study of the heat induced unfolding and aggregation process of Myoglobin. Biophys. J. 85:19591967.
28. Zhang, J., and Y.-B. Yan. 2005. Probing conformational changes of proteins by quantitative second derivative infrared spectroscopy. Anal. Biochem. 340:8998.[CrossRef][Medline]
29. Noda, I. 1993. Generalized two-dimensional correlation method applications to infrared, Raman, and other types of spectroscopy. Appl. Spectrosc. 47:13291336.[CrossRef]
30. He, H.-W., J. Zhang, H.-M. Zhou, and Y.-B. Yan. 2005. Conformational change in the C-terminal domain is responsible for the initiation of creatine kinase thermal aggregation. Biophys. J. 89:26502658.
31. Turoverov, K. K., S. Y. Haitlina, and G. P. Pinaev. 1976. Ultra-violet fluorescence of actin. Determination of actin content in actin preparations. FEBS Lett. 62:46.[CrossRef][Medline]
32. Burstein, E. A., S. M. Abornev, and Y. K. Reshetnyak. 2001. Decomposition of protein tryptophan fluorescence spectra into log-normal components. I. Decomposition algorithms. Biophys. J. 81:16991709.
33. Reshetnyak, Y. K., and E. A. Burstein. 2001. Decomposition of protein tryptophan fluorescence spectra into log-normal components. II. The statistical proof of discreteness of tryptophan classes in proteins. Biophys. J. 81:17101734.
34. Reshetnyak, Y. K., Y. Koshevnik, and E. A. Burstein. 2001. Decomposition of protein tryptophan fluorescence spectra into log-normal components. III. Correlation between fluorescence and microenvironment parameters of individual tryptophan residues. Biophys. J. 81:17351758.
35. Bushmarina, N. A., I. M. Kuznetsova, A. G. Biktashev, K. K. Turoverov, and V. N. Uversky. 2001. Partially folded conformations in the folding pathway of bovine carbonic anhydrase II: a fluorescence spectroscopic analysis. ChemBioChem. 2:819821.
36. Berkowitz, S. A., G. Velicelebi, J. W. H. Sutherland, and J. M. Sturtevant. 1980. Observation of an exothermic process associated with the in vitro polymerization of brain tubulin. Proc. Natl. Acad. Sci. USA. 77:44254429.
37. Pelton, J. T., and L. R. McLean. 2002. Spectroscopic methods for analysis of protein secondary structure. Anal. Biochem. 277:167176.
38. Fabian, H., H. H. Mantsch, and C. P. Schultz. 1999. Two dimensional IR correlation spectroscopy: sequential events in the unfolding process of the
Cro-V55C repressor protein. Proc. Natl. Acad. Sci. USA. 96:1315313158.
39. Dong, A., T. W. Randolph, and J. F. Carpenter. 2000. Entrapping intermediates of thermal aggregation in
-helical proteins with low concentration of guanidine hydrochloride. J. Biol. Chem. 275:2768927693.
40. Paquet, M.-J., M. Laviolette, M. Pézolet, and M. Auger. 2001. Two-dimensional infrared correlation spectroscopy study of the aggregation of cytochrome c in the presence of dimyristoylphosphatidylglycerol. Biophys. J. 81:305312.
41. Noda, I. 2004. Advances in two-dimensional correlation spectroscopy. Vib. Spectrosc. 36:143165.[CrossRef]
42. Yan, Y.-B., J. Zhang, H.-W. He, and H.-M. Zhou. 2006. Oligomerization and aggregation of bovine pancreatic ribonuclease A: characteristic events observed by FTIR spectroscopy. Biophys. J. 90:25252533.
43. Jackson, M., and H. H. Mantsch. 1995. The use and misuse of FTIR spectroscopy in the determination of protein structure. Crit. Rev. Biochem. Mol. Biol. 30:95120.[Medline]
44. Manas, E. S., Z. Getahun, W. W. Wright, W. F. DeGrado, and J. M. Vanderkooi. 2000. Infrared spectra of amide groups in
-helical proteins: evidence for hydrogen bonding between helices and water. J. Am. Chem. Soc. 122:98839890.[CrossRef]
45. Walsh, S. S. T., R. P. Cheng, W. W. Wright, D. O. Alonso, V. Daggett, J. M. Vanderkooi, and W. F. DeGrado. 2003. The hydration of amides in helices; a comprehensive picture from molecular dynamics, IR, and NMR. Protein Sci. 12:520531.
46. Czarnecki, M. A. 2000. Two-dimensional correlation sSpectroscopy: effect of band position, width, and intensity changes on correlation intensities. Appl. Spectrosc. 54:986993.[CrossRef]
47. Mitta, M., H. Ohnogi, A. Yamamoto, I. Kato, F. Sakiyama, and S. Tsunasawa. 1992. The primary structure of porcine aminoacylase 1 deduced from cDNA sequence. J. Biochem. (Tokyo). 112:737742.
48. Jakob, M., Y. E. Miller, and K. H. Rohm. 1992. Cloning and sequence analyses of cDNAs encoding aminoacylase I from porcine kidney. Biol. Chem. Hoppe Seyler. 373:12271231.[Medline]
49. Burgess, A. W., and H. A. Scheraga. 1975. A hypothesis for the pathway of the thermally-induced unfolding of bovine pancreatic ribonuclease. J. Theor. Biol. 53:403420.[CrossRef][Medline]
50. Matheson, R. R., and H. A. Scheraga. 1979. Steps in the pathway of the thermal unfolding of ribonuclease A. A nonspecific photochemical surface-labeling study. Biochemistry. 18:24372445.[CrossRef][Medline]
51. Yan, Y.-B., Q. Wang, H.-W. He, and H.-M. Zhou. 2004. Protein thermal aggregation involves distinct regions: sequential events in the heat-induced unfolding and aggregation of hemoglobin. Biophys. J. 86:16821690.
52. Vermeer, A. W. P., and W. Norde. 2000. The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein. Biophys. J. 78:394404.
53. Stelea, S. D., P. Pancoska, A. S. Benight, and T. A. Keiderling. 2001. Thermal unfolding of ribonuclease A in phosphate at neutral pH: deviations from two-state model. Protein Sci. 10:970978.
54. Stelea, S. D., and T. A. Keiderling. 2002. Pretransitional structural changes in the thermal denaturation of ribonuclease S and S protein. Biophys. J. 83:22592269.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |